Boothbay Fund Management, LLC Novo Cure LTD Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$56.44 - $118.81 $2.02 Million - $4.25 Million
35,800 Added 33.49%
142,700 $8.58 Million
Q4 2022

Feb 14, 2023
BUY
$63.98 - $85.37 $6.84 Million - $9.13 Million
106,900 New
106,900 $7.84 Million
Q4 2021

Feb 14, 2022
SELL
$75.08 - $121.99 $2.03 Million - $3.29 Million
-27,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$116.17 - $194.55 $3.14 Million - $5.25 Million
27,000 New
27,000 $3.14 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.37B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email